211 related articles for article (PubMed ID: 19729837)
1. A simple biological imaging system for detecting viable human circulating tumor cells.
Kojima T; Hashimoto Y; Watanabe Y; Kagawa S; Uno F; Kuroda S; Tazawa H; Kyo S; Mizuguchi H; Urata Y; Tanaka N; Fujiwara T
J Clin Invest; 2009 Oct; 119(10):3172-81. PubMed ID: 19729837
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.
Ito H; Inoue H; Sando N; Kimura S; Gohda K; Sato J; Murakami K; Ito S; Odaka N; Satodate H; Kudo SE
BMC Cancer; 2012 Aug; 12():346. PubMed ID: 22873704
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics.
Shigeyasu K; Tazawa H; Hashimoto Y; Mori Y; Nishizaki M; Kishimoto H; Nagasaka T; Kuroda S; Urata Y; Goel A; Kagawa S; Fujiwara T
Gut; 2015 Apr; 64(4):627-35. PubMed ID: 24870621
[TBL] [Abstract][Full Text] [Related]
4. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
[TBL] [Abstract][Full Text] [Related]
5. Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.
Yabusaki M; Sato J; Kohyama A; Kojima T; Nobuoka D; Yoshikawa T; Sawada Y; Murakami K; Gohda K; Okegawa T; Nakamura M; Takamatsu K; Ito M; Kaneko K; Nakatsura T
Oncol Rep; 2014 Nov; 32(5):1772-8. PubMed ID: 25176113
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of human cancer with telomerase-specific replication-selective adenovirus.
Fujiwara T
Methods Mol Biol; 2012; 872():129-39. PubMed ID: 22700408
[TBL] [Abstract][Full Text] [Related]
7. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
8. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential and limitation of imaging cancer cells in cytological samples using telomerase-specific replicative adenovirus.
Maida Y; Kyo S; Sakaguchi J; Mizumoto Y; Hashimoto M; Mori N; Ikoma T; Nakamura M; Takakura M; Urata Y; Fujiwara T; Inoue M
Int J Oncol; 2009 Jun; 34(6):1549-56. PubMed ID: 19424572
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
Fujiwara T; Urata Y; Tanaka N
Front Biosci; 2008 Jan; 13():1881-6. PubMed ID: 17981675
[TBL] [Abstract][Full Text] [Related]
12. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
Ikemoto S; Sakurai F; Tokuoka S; Yamashita T; Takayama K; Hoshi K; Okabe T; Sumiyoshi I; Togo S; Takahashi K; Tachibana M; Mizuguchi H
PLoS One; 2023; 18(10):e0286323. PubMed ID: 37856461
[TBL] [Abstract][Full Text] [Related]
13. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.
Sasaki T; Tazawa H; Hasei J; Osaki S; Kunisada T; Yoshida A; Hashimoto Y; Yano S; Yoshida R; Kagawa S; Uno F; Urata Y; Ozaki T; Fujiwara T
Gene Ther; 2013 Jan; 20(1):112-8. PubMed ID: 22241176
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients: a prospective study.
Ito H; Inoue H; Kimura S; Ohmori T; Ishikawa F; Gohda K; Sato J
Int J Oncol; 2014 Jul; 45(1):227-34. PubMed ID: 24788213
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers.
Takakura M; Kyo S; Nakamura M; Maida Y; Mizumoto Y; Bono Y; Zhang X; Hashimoto Y; Urata Y; Fujiwara T; Inoue M
Br J Cancer; 2012 Jul; 107(3):448-54. PubMed ID: 22735905
[TBL] [Abstract][Full Text] [Related]
16. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.
Kishimoto H; Urata Y; Tanaka N; Fujiwara T; Hoffman RM
Mol Cancer Ther; 2009 Nov; 8(11):3001-8. PubMed ID: 19887549
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729
[TBL] [Abstract][Full Text] [Related]
19. [Theranostic application of telomerase-specific oncolytic adenovirus for human cancer].
Fujiwara T; Tanaka N
Nihon Rinsho; 2007 Oct; 65(10):1913-22. PubMed ID: 17926546
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.
Sato D; Kurihara Y; Kondo S; Shirota T; Urata Y; Fujiwara T; Shintani S
Oncol Rep; 2013 Dec; 30(6):2659-64. PubMed ID: 24065118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
